title: Editorial Comment to Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate and high-risk prostate cancer.
authors.affiliation: Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan. yoshioka@radonc.med.osaka-u.ac.jp.
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Yoshioka
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000628:therapy*; D050397:Radiotherapy, Intensity-Modulated
chemical_list: D000726:Androgen Antagonists